SB184 Alabama 2012 Session

Summary

Primary Sponsor

Tammy Irons

Democrat

Co-Sponsors

William “Bill” M. BeasleyTrip PittmanQuinton RossRoger Bedford, Jr.George M. “Marc” KeaheyVivian Davis FiguresDick Brewbaker

Session

Regular Session 2012

Title

Ephedrine, pseudoephedrine, and phenylpropanolamine, State Board of Health required to classify as controlled substances, exemptions, removed from list of precursor chemicals maintained by State Board of Pharmacy, Secs. 20-2-20, 20-2-181 am'd.

Summary

SB184 would require ephedrine, pseudoephedrine, and phenylpropanolamine to be classified as Schedule III controlled substances in Alabama, with possible exemptions for products formulated to prevent meth production and a mechanism to revoke those exemptions.

What This Bill Does

It directs the State Board of Health to classify the three substances as Schedule III controlled substances. It also allows the board to exempt a product containing any of these substances from control if the product is effectively formulated to prevent conversion to methamphetamine, and lets the board revoke the exemption if the Department of Public Safety finds the product no longer effectively prevents conversion. The bill also requires the Board of Pharmacy to designate listed precursor chemicals and to mirror federal designations after notice, using a 30-day window for objections and hearings; until a rule is adopted, these substances are treated as listed precursors. The act becomes effective on the first day of the third month after passage and governor approval.

Who It Affects

• Public consumers who use medicines containing ephedrine, pseudoephedrine, or phenylpropanolamine, as these ingredients would generally require prescription under Schedule III unless a product is exempted by the Board of Health.
• Manufacturers, retailers, and regulators (including the State Board of Health, Department of Public Safety, and the Board of Pharmacy), who would handle product exemptions, potential revocations, and the listing/management of precursor chemicals.

Key Provisions

• The State Board of Health must classify ephedrine, pseudoephedrine, and phenylpropanolamine as Schedule III controlled substances.
• The Board may exempt a product containing any of these substances from classification as a controlled substance if the product is effectively formulated to prevent conversion to methamphetamine or its precursors.
• The Board may revoke an exemption if the Department of Public Safety notifies that the exempt product does not effectively prevent conversion to methamphetamine.
• The Board of Pharmacy shall designate listed precursor chemicals and may add or delete chemicals; it must align state listings with federal designations after notice and provide due process (objections/hearings) for changes.
• Until the Board of Pharmacy adopts a rule, ephedrine, pseudoephedrine, and phenylpropanolamine are deemed listed precursor chemicals.

AI-generated summary using openai/gpt-5-nano on Feb 25, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Controlled Substances